Does RILMENIDINE Cause Hepatocellular carcinoma? 5 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatocellular carcinoma have been filed in association with RILMENIDINE. This represents 0.6% of all adverse event reports for RILMENIDINE.
5
Reports of Hepatocellular carcinoma with RILMENIDINE
0.6%
of all RILMENIDINE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hepatocellular carcinoma From RILMENIDINE?
Of the 5 reports, 5 (100.0%) required hospitalization.
Is Hepatocellular carcinoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RILMENIDINE. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does RILMENIDINE Cause?
Acute kidney injury (214)
Lactic acidosis (121)
Fall (120)
Hyperkalaemia (86)
Hypotension (85)
Hypoglycaemia (59)
Diarrhoea (49)
Bradycardia (45)
Rhabdomyolysis (44)
Drug ineffective (41)
What Other Drugs Cause Hepatocellular carcinoma?
SORAFENIB (1,665)
RIBAVIRIN (1,046)
SOFOSBUVIR (877)
LEDIPASVIR\SOFOSBUVIR (640)
BEVACIZUMAB (532)
REGORAFENIB (470)
DACLATASVIR (419)
ATEZOLIZUMAB (342)
CABOZANTINIB S-MALATE (219)
TACROLIMUS (183)
Which RILMENIDINE Alternatives Have Lower Hepatocellular carcinoma Risk?
RILMENIDINE vs RILONACEPT
RILMENIDINE vs RILPIVIRINE
RILMENIDINE vs RILUZOLE
RILMENIDINE vs RIMABOTULINUMTOXINB
RILMENIDINE vs RIMEGEPANT